Carregant...
Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: Results of a phase 1 study
We conducted a phase 1 trial evaluating the oral nucleoside analogue clofarabine in patients with relapsed/refractory non-Hodgkin lymphoma. Patients were treated once daily on days 1 through 21 of a 28 day cycle for a maximum of 6 cycles. The study was conducted with a 3+3 design with ten additional...
Guardat en:
| Publicat a: | Leuk Lymphoma |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4595907/ https://ncbi.nlm.nih.gov/pubmed/23289359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.763397 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|